佩蒂股份(300673) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 reached ¥384,361,410.15, representing a 142.37% increase compared to ¥158,582,024.06 in the same period last year[5] - Net profit attributable to shareholders was ¥41,712,068.74, a significant turnaround from a loss of ¥38,073,427.83 in Q1 2023, marking a 209.56% increase[5] - Basic and diluted earnings per share increased to ¥0.17 from -¥0.15, reflecting a 213.33% improvement[5] - Total operating revenue for the first quarter reached ¥384,361,410.15, a significant increase from ¥158,582,024.06 in the previous period, representing a growth of approximately 142.5%[34] - The net profit for the quarter was ¥41,855,415.66, a turnaround from a net loss of ¥37,953,613.94 in the same period last year[35] - The company reported a total comprehensive income of ¥17,360,159.57, compared to a loss of ¥51,122,582.27 in the previous year[35] Cash Flow and Assets - The net cash flow from operating activities improved by 28.21%, amounting to -¥39,664,159.28, compared to -¥55,246,942.08 in the previous year[5] - Cash flow from operating activities showed a net outflow of ¥39,664,159.28, an improvement from a net outflow of ¥55,246,942.08 in the prior period[36] - Cash received from sales and services increased by 58.98% to ¥354,441,991.87, up from ¥222,941,950.11 in the same period last year[15] - Cash and cash equivalents decreased to RMB 739,602,092.69 from RMB 816,092,861.85[30] - The company's cash and cash equivalents at the end of the period totaled ¥736,043,227.69, down from ¥784,854,447.61 at the end of the previous period[38] Liabilities and Equity - The company's total liabilities decreased by 70.25% for non-current liabilities due within one year, amounting to ¥3,195,493.33, down from ¥10,741,083.80[10] - The total liabilities of the company were RMB 1,043,752,145.65, down from RMB 1,054,370,901.75[31] - The company's total equity as of March 31, 2024, was RMB 1,869,124,130.85, compared to RMB 1,882,082,998.41 at the beginning of the period[32] Shareholder Information - The total number of common shareholders at the end of the reporting period is 15,201[17] - The largest shareholder, Chen Zhenbiao, holds 31.69% of the shares, totaling 80,318,800 shares[17] - The company repurchased 9,730,643 shares, representing 3.84% of the total share capital at the end of the reporting period[18] - The top ten shareholders hold a significant portion of the company's shares, with the top three shareholders alone holding over 45%[17] - The company has not disclosed any other related party relationships or concerted actions among shareholders beyond those mentioned[18] Strategic Initiatives and Future Outlook - The company plans to repurchase shares using self-owned funds ranging from RMB 50 million to 100 million, with a maximum repurchase price of RMB 20 per share[26] - Future outlook indicates a projected revenue growth of 10-12% for the full year 2024, driven by new product launches and market expansion[40] - The company is investing 100 million RMB in R&D for new nutritional products aimed at enhancing animal health[40] - Market expansion efforts include entering three new provinces, expected to contribute an additional 200 million RMB in revenue[40] - The company plans to explore strategic acquisitions to enhance its product portfolio and market presence[40] Operational Efficiency - The company achieved a net profit margin of 20%, reflecting a strong operational efficiency compared to 18% in the previous year[40] - The gross margin improved to 35%, up from 32% in the previous year, indicating better cost management[40] - User data showed a 25% increase in active customers, totaling 500,000 users as of Q1 2024[40] - The average repurchase price during the buyback was RMB 10.2808 per share, with a total transaction amount of RMB 29,635,019.30[26] Corporate Governance - The company has completed the election of the fourth board of directors and appointed senior management personnel on January 19, 2024[23] - The company has completed adjustments to its independent director system to comply with regulatory requirements[25] - The company elected a new supervisory board, with a term of three years starting from the date of the shareholders' meeting[24]